---
title: "WAVE trial update reports sustained 12-month survival benefit"
date: "2025-04-09T13:39:48.000Z"
publishedDate: "9 avril 2025"
summary: "Twelve-month results from the WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial show a statistically significant improvement in target lesion primary patency (TLPP) with the Wrapsody (Merit Medical) cell-impermeable endoprosthesis (CIE) when compared to percutaneous transluminal angioplasty (PTA). The prospective, multicentre, international WAVE trial, conducted across 43 centres in the USA, South America and the UK, [&#8230;] The post WAVE trial update reports sustained 12-month survival benefit appeared first on Interventional News ."
importance: ""
sourceUrl: "https://interventionalnews.com/wave-trial-update-reports-sustained-12-month-survival-benefit/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2025-04-09-wave-trial-update-reports-sustained-12-month-survival-benefit"
imageUrl: "http://interventionalnews.com/wp-content/uploads/sites/13/2025/01/Wrapsody-device-feature-image.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/wave-trial-update-reports-sustained-12-month-survival-benefit/"
---

![WAVE trial update reports sustained 12-month survival benefit](http://interventionalnews.com/wp-content/uploads/sites/13/2025/01/Wrapsody-device-feature-image.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/wave-trial-update-reports-sustained-12-month-survival-benefit/*

## L’essentiel

Twelve-month results from the WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial show a statistically significant improvement in target lesion primary patency (TLPP) with the Wrapsody (Merit Medical) cell-impermeable endoprosthesis (CIE) when compared to percutaneous transluminal angioplasty (PTA). The prospective, multicentre, international WAVE trial, conducted across 43 centres in the USA, South America and the UK, [&#8230;] The post WAVE trial update reports sustained 12-month survival benefit appeared first on Interventional News .

## Lien source

https://interventionalnews.com/wave-trial-update-reports-sustained-12-month-survival-benefit/
